Kelvin Kering

Research Scientist-KEMRI || PhD Student- UoN || Enteric pathogens, AMR, Phages, Bacterial Vaccines.

[Daily Nation @NationAfrica]

Prof Faith Osier: The Kenyan scientist bringing vaccine manufacturing closer home #HealthyNation
https://t.co/hEWEIvP5vV

[Dr. Priyam Bordoloi @DocPriyamMD]

Antibiotic resistance means one day
a simple cut could kill like it did 100 years ago.

[Take on Typhoid @PreventTyphoid]

A new study found that #typhoid continues to affect millions in #India, with rising #DrugResistance making the disease more dangerous and harder to treat.

Read more in @TheLancet Regional Health: https://t.co/fbgJPTARl3

#TakeOnTyphoid #AMR

[IDeAL, Africa @IDeAL_KEMRI_WT]

A fully funded PhD studentship is now open.
Join a global research team to tackle neonatal sepsis and antimicrobial resistance in Kenyan maternity wards using genomics, microbiome science, and machine learning.
Deadline: January 15, 2026
Apply now: https://t.co/jUZdudLaUv

[Ruth Nanjala @Ruthnanje]

Join us @UniofOxford! Shoot your shot!
Projects link: https://t.co/mT9wJDkndG

To be a bit biased, my brilliant supervisor @yluo86 has an amazing project listed. What are you waiting for?

[Take on Typhoid @PreventTyphoid]

📢 #Kenya is introducing #typhoid conjugate vaccines (TCVs), launching a milestone campaign to protect 21M children from typhoid. Congratulations to the leaders in Kenya and the partners who made it happen!

@WHOAFRO @Gavi @PATHtweets @UNICEFKenya @MOH_Kenya

[The Fleming Fund @FlemingFund]

🌍A new study, led by the #MAAP research consortium, covering 14 African countries from 2016-2019, published @PLOSMedicine, finds resistance to critical antibiotics used to treat severe bacterial infections is widespread and has significant variations.

https://t.co/EQWdyyxyUm

[Take on Typhoid @PreventTyphoid]

🆕 Researchers at @Cornell identified an antibiotic, rifampin, that is 99.9% effective against Salmonella Typhi, the bacterium that causes #typhoid.

The likelihood of encountering rifampin-resistant typhoid cases is less than 1 in every 1,000 cases, according to the findings.

Read more: https://t.co/DrxFqENW0Y

#TakeOnTyphoid

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

🚨 This is Big!

New GARDP research shows that people with multidrug-resistant infections in LMICs are not receiving the appropriate antibiotics because of large gaps in access. Improving access and developing new antibiotics must be a priority,

📖 Read the study 👇
https://t.co/T0AYkMqrI5

[African Society of Human Genetics @AfSHG_Genetics]

Are you interested in a MSc in Bioinformatics of Infectious Diseases and Pathogen Genomics? This opportunity at Stellenbosch University is highly recommended— apply now if you’re interested.

Deadline: 26 June 2025

More details below ⬇️

[AfredacUbuntu @afredac]

This opportunity is for early-career researchers eager to develop their own groundbreaking contributions to human life, health, and wellbeing. It was shared on the Afredac Ubuntu Platform 4 days ago!

Visit https://t.co/IsREj5KT0b to read more and check other opportunities!

[Doris Wangari @DorisWangariN]

The #GlobalAISummit2025 in Kigali was eye-opening!
Powerful insights on AI’s role across sectors, need for infrastructure & access, and ethical use to prevent widening inequalities.
Loved the idea: AI = African Intelligence
As H.E. @PaulKagame said, Africa must lead, not follow!

[Mark Blaskovich @mark_blaskovich]

A new Gram-negative antibiotic from a novel chemical class! Gepotidacin is a triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by interaction with DNA gyrase and topoisomerase IV (similar target as quinolones, but different site).
https://t.co/bLGt1ZOGQ3

[Kelvin Kering @KeringKev]

@flashton2003 @daanensen @TheCGPS Congratulations Phil

[Tulio de Oliveira @Tuliodna]

OPEN for Applications! African STARS Fellowship program - Spend 4 months with us at CERI or IPD to receive advanced training in genomics, diagnostics, and/or vaccine development. Unique opportunity to early-career scientist born in or based in Africa - https://t.co/f05L8LCQHz

[Kelvin Kering @KeringKev]

Happy to join colleagues from East Africa during the second workshop of the 2nd COHORT of Young East Africa Research Scientists (YEARS) Forum.

[George O'Toole (he/him/his) @GeiselBiofilm]

Pls share: Postdoc position in microbiology with a focus on antibiotic heteroresistance

[WACCBIP @WACCBIP_UG]

We're inviting applications from researchers across Africa working in Antimicrobial Resistance (AMR), surveillance, or epidemiology and Individuals with basic knowledge in Molecular Biology for our upcoming hands-on training on AMR, Bacterial Genomics & Bioinformatics scheduled for January 2025.

Learn more and apply at https://t.co/emDSyr4LdI
#AMR #Bioinformatics #Training
#Research #Africa

[NEJM @NEJM]

Investigators report broad dissemination of a highly drug-resistant Vibrio cholerae O1 El Tor strain across Africa. Read the full correspondence: https://t.co/CFVcKNNnYf

[Didier Mazel @amazeld]

We are opening a call for applications 2025 – Creation of new junior research groups at the Institut Pasteur in Paris @institutpasteur All details on our web site : https://t.co/TaFsiZTnPi